The enteric disease testing market has a lot to offer for the global vendors, especially in the developing regions of the world. Meridian Bioscience, DiaSorin, Biomerica, Alere, and Cepheid are some of the influential vendors operating in the international enteric disease testing market. Over 85% of enteric infections are accounted by emerging nations. As per Centers for Disease Control and Prevention (CDC), an estimated 2.0 mn children die each year, primarily in developing countries, due to diarrheal and enteric diseases.
The global market for enteric disease testing is foreseen to touch approximately 1.01 bn in 2019, according to a market intelligence report by Transparency Market Research (TMR).
Get Sample Report:
Will Traditional Culturing Survive Against Newer Enteric Testing Methods?
The traditional culture methods have lost focus due to their time consuming and labor intensive aspects. New methodologies such as polymerase chain reaction (PCR) and enzyme linked immunoassay (ELISA) have made the cut by allowing the much needed rapid testing of enteric diseases.
The untapped markets of emerging nations are a great opportunity for entering the global enteric disease testing market. Rapid dipstick tests are anticipated to exhibit a strong demand on the back of their user-friendly and inexpensive attributes. Such tests can also be performed by patients and involve diagnosis which do not require a laboratory setting. However, novel technology based tests such as enzyme immunoassay (EIA) and PCR may witness a growing demand in developing nations, such as China, India, Brazil, and Mexico, with better economic conditions.
Conventional culture methods are beaten once again on the ground of accuracy and specificity, which otherwise can be provided at a higher level by the application of molecular diagnostics, such as PCR, ELISA, and matrix-assisted laser desorption/ionization and time of flight (MALDI-TOF) mass spectrometry.
Which Factors Could Pose Threat to the Global Market?
Millions of enteric disease cases are detected every year due to the medically ignorant and educationally backward population of the developing economies in regions such as Asia Pacific, Latin America, and Africa. Thus, the prevalence of enteric diseases due to lack of awareness is significant in the emerging geographies of the world. Another restraint could be the mild and asymptomatic nature of enteric diseases which has led to the ignorance of the diagnostic testing required.
Howbeit, the paradigm shift from traditional testing techniques to molecular diagnostic testing has opened opportunities in the global enteric disease testing market. The newer methods can easily diagnose the pathogens and viruses, which was difficult, slow, and expensive with the application of culturing methods. Developing countries such as India, China, South Africa, Morocco, Kenya, and Algeria are poised to push the global market at a substantial high, owing to low awareness, high population, and poor sanitization.
Which Emerging Economy will Grow Faster Demand?
In the recent past, North America, as the U.S. and Canada collectively, held a king’s share in the global enteric disease testing market. It is expected to continue demonstrating dominance until the end of the forecast period 2013–2019. The primary growth factors of the market include the rising need for accurate and rapid diagnosis of enteric diseases and demand for molecular diagnostic techniques such as PCR.
Latin America is predicted to exhibit a stallion growth in the global market while riding on increasing health expenditure and presence of large patient pool.